Early Changes in Tumor Size in Patients Treated for Advanced Stage Nonsmall Cell Lung Cancer Do Not Correlate With Survival

被引：2
|
作者：
Oxnard, Geoffrey R. [1 ]
Schwartz, Lawrence H. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA
来源：
CANCER | 2010年 / 116卷 / 06期
关键词：
D O I：
10.1002/cncr.24803
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1615 / 1615
页数：1
相关论文
共 50 条
  • [31] Impact of tumor size on the long-term survival of patients with early stage renal cell cancer
    Kuczyk, M
    Wegener, G
    Merseburger, AS
    Anastasiadis, A
    Machtens, S
    Zumbrägel, A
    Hartmann, JT
    Bokemeyer, C
    Jonas, U
    Stenzl, A
    WORLD JOURNAL OF UROLOGY, 2005, 23 (01) : 50 - 54
  • [32] Prognostic impact of baseline tumor size (BTS) on survival outcomes in patients (pts) with untreated advanced nonsmall cell lung cancer (NSCLC), PD-L1 ≥50%, treated with pembrolizumab alone
    Bureau, M.
    Chatelier, T.
    Perennec, T.
    Goronflot, T.
    Greilsamer, C.
    Chene, A-L.
    Affi, R.
    Bennouna, J.
    Pons-Tostivint, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S1004 - S1004
  • [33] Outcomes of Patients With Stage III Nonsmall Cell Lung Cancer Treated With Chemotherapy and Radiation With and Without Surgery
    Caglar, Hale B.
    Baldini, Elizabeth H.
    Othus, Megan
    Rabin, Michael S.
    Bueno, Raphael
    Sugarbaker, David J.
    Mentzer, Steven J.
    Janne, Pasi A.
    Johnson, Bruce E.
    Allen, Aaron M.
    CANCER, 2009, 115 (18) : 4156 - 4166
  • [34] Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer
    Cerfolio, Robert J.
    Bryant, Ayesha S.
    ANNALS OF THORACIC SURGERY, 2008, 86 (02): : 362 - 367
  • [35] Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?
    Herndon, JE
    Fleishman, S
    Kornblith, AB
    Kosty, M
    Green, MR
    Holland, J
    CANCER, 1999, 85 (02) : 333 - 340
  • [36] The effect of the ratio between angiogenic and antiangiogenic factors on patients' survival in advanced nonsmall cell lung cancer
    Demir, V
    Demir, M.
    Cicin, I
    Pamuk, G. E.
    Ozturk, E.
    Tekgunduz, E.
    Caglar, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 608 - 608
  • [37] Epithelial-mesenchymal transition changes in nonsmall cell lung cancer patients with early COPD
    Lu, Wenying
    Eapen, Mathew Suji
    Hardikar, Ashutosh
    Chia, Collin
    Robertson, Iain
    Singhera, Gurpreet Kaur
    Hackett, Tillie L.
    Sohal, Sukhwinder Singh
    ERJ OPEN RESEARCH, 2023, 9 (06)
  • [38] Pretreatment prognostic factors in patients with early stage (VII) nonsmall cell lung cancer treated wth hyperfactionated radiation therapy alone
    Jeremic, B
    Milicic, B
    Dagovic, A
    Radosavljevic-Asic, G
    LUNG CANCER, 2005, 49 : S94 - S94
  • [39] Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
    Tfayli, Arafat
    Al Assaad, Majd
    Fakhri, Ghina
    Akel, Reem
    Atwi, Hanine
    Ghanem, Hady
    El Karak, Fadi
    Farhat, Fadi
    Al Rabi, Kamal
    Sfeir, Pierre
    Youssef, Pierre
    Mansour, Ziad
    Assi, Hazem
    Haidar, Mohamad
    Abi Ghanem, Alain
    Khalifeh, Ibrahim
    Boulos, Fouad
    Mahfouz, Ramy
    Youssef, Bassem
    Zeidan, Youssef
    Bejjany, Rachelle
    Khuri, Fadlo
    CANCER MEDICINE, 2020, 9 (22): : 8406 - 8411
  • [40] Brain Metastasis is an Early Manifestation of Distant Failure in Stage III Nonsmall Cell Lung Cancer Patients Treated With Radical Chemoradiation Therapy
    Germain, Francois
    Wai, Elaine S.
    Berthelet, Eric
    Truong, Pauline T.
    Lesperance, Mary
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (06): : 561 - 566
12345